The global Therapeutic BCG vaccines market is expected to grow at a significant CAGR during the forecast period (2021-2027). The Bacillus Calmette-Guérin (BCG) vaccine has achieved international acceptance as a safe tuberculosis vaccination (TB). Mycobacterium Bovis, the etiological agent of tuberculosis, has also been employed in many immunisation programmes globally. This is also owing to their efficiency in combating a variety of different mycobacterial illnesses, including Buruli ulcer disease. The repeated imbalance between demand and supply has defined the BCG vaccines sales industry, a worry that has been practically constant over the decades. Stock-outs have had a significant influence on BCG vaccine sales, particularly in low- and middle-income nations.

The dynamic of supply to economies has been determined globally by the expanded program on Immunization (EPI). This has had a significant impact on the demand for BCG vaccines. Notably, numerous high-income countries (HICs) have recently experienced supply shortages. Stock-outs are the result of a combination of microeconomic and macroeconomic environmental conditions.

Manufacturers' concerns about good manufacturing procedures (GMP) are one of the most important macroenvironmental elements influencing the dynamics of the global therapeutic BCG vaccines market. On the other hand, frequent production halts, instability in raw material availability, and a lack of corresponding developments in production methods are all major impediments to sustained vaccination sales. Owing to the growing concern about protecting newborns from severe diseases, the demand for BCG vaccines has increased in the global market. In essence, BCG vaccines are used to immunise people against tuberculosis and other infections. As a result, the global therapeutic BCG vaccines market is expected to rise in the coming years. Sales of BCG vaccines have been in high demand since the vaccine's debut. This is due to the medical community has been particularly receptive to new vaccinations and therapy mechanisms becoming available. Improvements in the field of vaccinations are projected to drive demand for BCG vaccines in the global market.

Market Coverage

• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered
• Regions Covered- Globally

Competitive Landscape: AJ Vaccines, China National Biotec Group, Green Signal Bio Pharma Pvt Ltd, GREENSIGNAL BIOPHARMA LIMITED. 

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominates the market in base year?
• Which segment and region will project fastest growth in the market?
• How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Therapeutic BCG Vaccines Market by Segment

By Type 

• Immune BCG 

• Therapy BCG 

By End-User 

• Adults 

• Pediatrics 

Global Therapeutic BCG Vaccines Market by Region